HOME >> BIOLOGY >> NEWS
Health of coral reefs detected from orbit

coverage constraints. We need a system that has appropriate coverage and revisit frequency, with a sufficient amount of spectral bands and sensitivity. There is no more suitable system than MERIS."

The team studied Heron Island reef at the southern end of the Great Barrier Reef, site of a University of Queensland research station. Validating MERIS Full Resolution mode results, they found that observed changes in live coral cover were correlated to an existing bleaching event.

Theoretical studies indicate that for each complete 300-metre pixel of coral under one metre of water it is possible to detect a 2% bleaching of live coral. MERIS should remain sensitive to detecting from 7-8% bleached coral even under ten metres of water.

"MERIS Full Resolution covers the world every three days, a bottleneck for global monitoring could be data processing," Dekker concludes. "However satellite sensors measuring sea surface temperature such as Envisat's Advanced Along Track Scanning Radiometer (AATSR) can be applied to prioritise reefs that are subject to sea temperature heating anomalies-thus focusing the MERIS based bleaching detection.

Australia's Great Barrier Reef Marine Park Authority has expressed interest in the project. Australian scientists plan to progress to perform MERIS monitoring of bleaching events up to the scale of the whole Great Barrier Reef.


'"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-06-941-80-856
European Space Agency
3-Oct-2005


Page: 1 2

Related biology news :

1. Sugar and spice and everything nice: Health differences in newborn girls and boys
2. Health Physics Society
3. Johns Hopkins Bloomberg School of Public Health, Geisinger launch new environmental research group
4. Health care reimagined: Improving patient care through early health
5. Healthy coral reefs hit hard by warmer temperatures
6. Healthy reefs hit hardest by warmer temperatures
7. Kent State University and Summa Health System receive NIH grant to study prehypertension
8. Health disparities -- Genetics, society and race play an important role in access to healthcare
9. OneWorld Health selects Odyssey Research for phase 4 study in India
10. Healthy coastal wetlands would adapt to rising oceans
11. New Geisinger Health System building green Center for Health Research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Health coral reefs detected from orbit

(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... -- According to a new market research ... Access Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), ... Geography - Global Forecasts to 2020", published by MarketsandMarkets, ... around $25 Billion in 2014 and is expected to ... of 8.69%. Browse 116 market data Tables ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
(Date:12/19/2014)... -- Decision Resources Group finds that the Asia ... through 2023 as the aging population, increasing adoption of ... all spur procedure volumes. Growth will be particularly rapid ... and India , where rising ... a larger proportion of the population. Other ...
(Date:12/17/2014)... NY (PRWEB) December 16, 2014 The ... changes since 2013, which is why IBISWorld updated its ... industry continues to benefit from an intensified focus on ... proposal for new emission standards for power plants and ... operators. According to IBISWorld Industry Analyst Sarah Kahn, “a ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: